Dechra relaunches Sedaxylan 20mg/mg solution
Sedaxylan provides flexible dosing options.
UK-based pharmaceutical company Dechra has relaunched Sedaxylan 20mg/ml solution for the sedation and premedication before general anaesthesia of dogs, cats, horses and cattle.
The sedative contains the short-acting alpha-2 against xylazine, is licensed for intravenous administration, and for intramuscular administration in cattle.
In cattle, sedation occurs within two minutes when administered intravenously, and five to 10 minutes intramuscularly.
National sales manager at Dechra, Alana McGlade, said: “Dechra offers a comprehensive range of anaesthesia and sedation products allowing vets to customise protocols to the individual animal. Sedaxylan 20mg/ml and Nerfasin vet 100 mg/ml solution provide vets with flexible and convenient dosing options.”
Veterinary professionals can find out more about Sedaxylan 20mg/ml solution by contacting their local Dechra territory sales manager, or visit the Dechra website.
Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.
